Filter
1723
Filtered Results: 1723
Text search:
Diabetes
Therapy
Featured
Recommendations
192
New Publications
442
Language
Document type
No document type
968
Guidelines
301
Studies & Reports
264
Manuals
86
Strategic & Response Plan
46
Training Material
23
Fact sheets
20
Situation Updates
6
Infographics
6
Brochures
1
App
1
Resource Platforms
1
Countries / Regions
India
141
Global
85
Kenya
55
South Africa
49
Western and Central Europe
40
Indonesia
33
Tanzania
30
Zambia
29
Ethiopia
28
Nepal
27
Latin America and the Carribbean
27
Nigeria
25
Bangladesh
25
Uganda
24
Rwanda
23
Eastern Europe
23
Malawi
21
Philippines
21
Namibia
20
Ukraine
18
Ghana
18
Africa
18
Germany
18
Myanmar / Burma
18
Sierra Leone
17
South–East Asia Region
16
Asia
13
Liberia
13
Lesotho
12
Brazil
12
Cambodia
10
Russia
9
Botswana
9
Eswatini/ Swaziland
9
Zimbabwe
8
Colombia
7
Syria
7
Congo, Democratic Republic of
7
East and Southern Africa
7
Argentina
7
Senegal
6
Peru
6
Mozambique
6
Venezuela
6
Middle East and North Africa
6
Afghanistan
5
West and Central Africa
5
Paraguay
5
Bolivia
5
Pakistan
5
Cameroon
4
Haiti
4
Jordan
4
Eastern Europe and Central Asia
4
Spain
4
Ecuador
4
Chile
3
Kyrgyzstan
3
USA
3
North America
3
United Kingdom
3
Lebanon
3
Sri Lanka
3
Georgia
3
Angola
3
Bhutan
3
Tajikistan
2
Switzerland
2
Timor Leste/ East Timor
2
Turkey
2
Iran
2
Albania
2
Laos
2
Guinea-Bissau
2
Saudi Arabia
2
Western Pacific Region
2
Jamaica
2
Vietnam
2
Egypt
2
Sudan
2
Libya
2
South Sudan
2
Iraq
2
Somalia
2
North Korea
1
Thailand
1
El Salvador
1
Benin
1
Gambia
1
Togo
1
China
1
Kazakhstan
1
Canada
1
Fiji
1
Burkina Faso
1
Morocco
1
Qatar
1
Bulgaria
1
Lithuania
1
France
1
Mauritius
1
Tunisia
1
Portugal
1
Latvia
1
Papua New Guinea
1
Moldova
1
Djibouti
1
Yemen
1
Greece
1
Palestine
1
Chad
1
Authors & Publishers
Publication Years
Category
Countries
759
Clinical Guidelines
198
Public Health
165
Women & Child Health
64
Key Resources
37
Capacity Building
24
Pharmacy & Technologies
10
Annual Report MEDBOX
1
Toolboxes
TB
193
Mental Health
148
COVID-19
137
NCDs
117
HIV
96
Caregiver
58
Pharmacy
47
Refugee
40
Disability
40
NTDs
38
Rapid Response
21
Conflict
18
AMR
18
Global Health Education
17
Planetary Health
13
Polio
11
Ebola & Marburg
9
Natural Hazards
7
Health Financing Toolbox
6
Zika
3
Cholera
2
Social Ethics
1
Malaria
1
In many low- and middle-income countries, there is a wide gap between evidencebased recommendations and current practice. Treatment of major CVD risk factors remains suboptimal, and only a minority of patients who are treated reach their target levels for blood pressure, blood sugar and blood choles...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, base...
Healthcare 2020, 8(1), 26; https://doi.org/10.3390/healthcare8010026
The current article is an integrative and analytical literature review on the concept and meaning of empathy in health and social care professionals. Empathy, i.e., the ability to understand the perso...
Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the European Society of Cardiology Guidelines for the t...
Viral hepatitis is defined as inflammation of the liver cells due to viral infection. The burden of liver disease in South Africa is mostly underestimated as viral hepatitis, in particular chronic infection, is a silent and neglected cause of morbidity and mortality. However, the burden of disease i...
Disabled village children. 2nd edition
recommended
A guide for community health workers, rehabilitation workers, and families.
This manual covers identifying primary and secondary disabilities, developing skills for daily living, and working through behavior problems. The new 2018 edition features new topics, including mental and developmental di...
Chapter 2 in "Latest Findings in Intellectual and Developmental Disabilities Research" Edited by Üner Tan, ISBN 978-953-307-865-6, 404 pages, Publisher: InTech, Chapters published February 15, 2012 under CC BY 3.0 license | Intellectual and Developmental Disabilities presents reports on a wide rang...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
Mental disorders impose an enormous burden on society, accounting for almost one in three years lived with disability globally. •In addition to their health impact, mental disorders cause a significant economic burden due to lost economic output and the link between mental disorders and costly, po...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
Q7. SCOPING QUESTION: In adults with moderate-severe depressive disorder, what is the effectiveness and safety of antidepressant medication (ADM) in comparison with psychological treatment?
The WHO mhGAP programme’s existing guidelines recommend that either structured brief psychological treatm...
Background
Low- and middle-income countries now experience the highest prevalence and mortality rates of cardiovascular disease.
Main text
While improving the availability and delivery of proven, effective therapies will no doubt mitigate this burden, we posit that studies evaluating cardiovasc...
The Government of the Republic of Zambia has placed priority on ensuring that Zambians are healthy and productive as a catalyst to the attainment of socioeconomic development . The Vision 2030 aims to transform Zambia into a prosperous middle-income country as articulated also in the 7th National De...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, ...
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An affordable TB vaccine for neonates and
infants with improved safety and efficacy.
3. A therapeutic v...
Mental health conditions affect one in 10 people at any one time and account for a large proportion of non-fatal disease burden. There is a high degree of comorbidity between mental health conditions such as depression and other noncommunicable diseases (NCDs), including cardiovascular disease, diab...
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
